| scholarly article | Q13442814 |
| P2093 | author name string | Izumi Takeyoshi | |
| Yasuo Morishita | |||
| Susumu Kawate | |||
| P2860 | cites work | Pharmacokinetics of paclitaxel and cisplatin in a hemodialysis patient with recurrent ovarian cancer | Q33337641 |
| Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer | Q33488159 | ||
| Treatment of advanced ovarian carcinoma with carboplatin and paclitaxel in a patient with renal failure | Q34176108 | ||
| Advanced gastric cancer with peritoneal dissemination successfully treated with paclitaxel and doxifluridine: a case report | Q46397042 | ||
| A combination phase I study of weekly paclitaxel and doxifluridine in advanced gastric cancer patients. | Q46467207 | ||
| Paclitaxel-induced apoptosis in human gastric carcinoma cell lines. | Q50754949 | ||
| Phase I clinical and pharmacokinetic study of taxol. | Q51791785 | ||
| Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. | Q53667890 | ||
| An early phase II study of a 3-hour infusion of paclitaxel for advanced gastric cancer. | Q54127938 | ||
| High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trial | Q69891308 | ||
| Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans | Q72354126 | ||
| Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients | Q72656539 | ||
| Pharmacokinetic and biochemical analysis in the treatment of weekly paclitaxel in relapsed breast cancer | Q74340270 | ||
| Phase II study of Taxol in patients with advanced gastric carcinoma | Q74835089 | ||
| P433 | issue | 32 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacokinetics | Q323936 |
| paclitaxel | Q423762 | ||
| hemodialysis patient | Q126109077 | ||
| P304 | page(s) | 5237-5239 | |
| P577 | publication date | 2006-08-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Pharmacokinetics of paclitaxel in a hemodialysis patient with advanced gastric cancer: A case report | |
| P478 | volume | 12 |
| Q33315395 | Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment |
| Q92854569 | Decreased Disposition of Anticancer Drugs Predominantly Eliminated via the Liver in Patients with Renal Failure |
| Q64922711 | Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors. |
| Q38893549 | Safety of Regular-Dose Imatinib Therapy in Patients with Gastrointestinal Stromal Tumors Undergoing Dialysis |
| Q37253762 | Weekly paclitaxel therapy for gastric cancer in patients with renal dysfunction: A case report |
Search more.